Author

J. L. Marin-Rubio

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:statistical model· 1

Frequent Co-Authors

M. Trost· 3 shared M. E. Duenas· 2 shared A. J. Simpson· 1 shared A. L. George· 1 shared A. Mendez-Alejandre· 1 shared B. B. A. Raymond· 1 shared B. Saxty· 1 shared F. R. Sidgwick· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

M. Trost

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistrybioRxivPreprintApr 3, 2023

Bi-functional particles for real-time acidification and proteolysis multiplex assay in macrophages

A. Mendez-Alejandre, B. B. A. Raymond, M. Trost, J. L. Marin-Rubio

The paper develops a multiplexed assay to simultaneously monitor phagosome acidification and proteolysis in macrophages using silica beads conjugated to pHrodo and DQ BSA.

DOI 10.1101/2023.04.03.535364

experimental assay

𝕏 PostBluesky

BiochemistrybioRxivFeb 15, 2023

A Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling

A. L. George, F. R. Sidgwick, J. E. Watt…·M. E. Duenas

This study compares DIA-based label-free quantification methods with TMT-DDA for thermal proteome profiling, finding DIA approaches are comparable or better for detecting drug target engagement.

DOI 10.1021/acs.jproteome.3c00111

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 29, 2021

A MALDI-TOF assay identifies nilotinib as an inhibitor of inflammation in acute myeloid leukaemia

J. L. Marin-Rubio, R. E. Heap, T. Heunis…·M. Trost

This study identifies nilotinib as an anti-inflammatory drug using a MALDI-TOF assay in AML-derived monocytes, showing it inhibits the p38-MK2/3 signaling axis.

DOI 10.1101/2021.03.29.437557

humanproteomics

𝕏 PostBluesky